Ketan Patel, Ph.D., joined St. John’s University as an Assistant Professor of Pharmaceutical Sciences in September of 2016. He holds a Ph.D. in Pharmaceutics from the Institute of Chemical Technology, Mumbai, India (2013) and an M.Pharm. from Mumbai University, India (2009). Following the completion of his Ph.D., he joined the Department of Pharmaceutical Sciences at Florida A&M University as a postdoctoral fellow on a National Institutes of Health-funded research project on lung cancer. He has been awarded All India Council for Technical Education and University Grants Commission Special Assistance Programme fellowships. He has received a number of oral ,poster, and travelship awards for the presentation of his research at various international conferences, including those organized by the American Association of Pharmaceutical Scientists and the Controlled Release Society. Dr. Patel has authored more than 50 research publications in prestigious, peer-reviewed journals in the areas of pharmaceutics, 3D printing, opioid abuse deterrent formulation, the pre-exposure prophylaxis of HIV, and cancer nanotechnology. He has five US patents (three received and two pending) on innovative formulation technologies. Dr. Patel recently received a Melanoma Research Scholar Award from Outrun the Sun, Inc. and a National Institutes of Health grant for his research on the development of nanomedicine via proteolysis targeting chimera (PROTAC) for the treatment of metastatic melanoma.
Ketan Patel, Ph.D., joined St. John’s University as an Assistant Professor of Pharmaceutical Sciences in September of 2016. He holds a Ph.D. in Pharmaceutics from the Institute of Chemical Technology, Mumbai, India (2013) and an M.Pharm. from Mumbai University, India (2009). Following the completion of his Ph.D., he joined the Department of Pharmaceutical Sciences at Florida A&M University as a postdoctoral fellow on a National Institutes of Health-funded research project on lung cancer. He has been awarded All India Council for Technical Education and University Grants Commission Special Assistance Programme fellowships. He has received a number of oral ,poster, and travelship awards for the presentation of his research at various international conferences, including those organized by the American Association of Pharmaceutical Scientists and the Controlled Release Society. Dr. Patel has authored more than 50 research publications in prestigious, peer-reviewed journals in the areas of pharmaceutics, 3D printing, opioid abuse deterrent formulation, the pre-exposure prophylaxis of HIV, and cancer nanotechnology. He has five US patents (three received and two pending) on innovative formulation technologies. Dr. Patel recently received a Melanoma Research Scholar Award from Outrun the Sun, Inc. and a National Institutes of Health grant for his research on the development of nanomedicine via proteolysis targeting chimera (PROTAC) for the treatment of metastatic melanoma.